-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 FmPU5Le11WevtQQxt04DGGC8juAAREN741zpmRoauRwkzamdhTc1Byz1TBew9KHP
 2i2E3mElpmUVEVHt0a8fzQ==

<SEC-DOCUMENT>0001209191-05-050613.txt : 20051004
<SEC-HEADER>0001209191-05-050613.hdr.sgml : 20051004
<ACCEPTANCE-DATETIME>20051004173650
ACCESSION NUMBER:		0001209191-05-050613
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20051003
FILED AS OF DATE:		20051004
DATE AS OF CHANGE:		20051004

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adams Respiratory Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001319439
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752725552
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		425 MAIN STREET
		CITY:			CHESTER
		STATE:			NJ
		ZIP:			07930
		BUSINESS PHONE:		(908) 879-1400

	MAIL ADDRESS:	
		STREET 1:		425 MAIN STREET
		CITY:			CHESTER
		STATE:			NJ
		ZIP:			07930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adams Laboratories, Inc.
		DATE OF NAME CHANGE:	20050302

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adams Respiratory Therapeutics, Inc.
		DATE OF NAME CHANGE:	20050301

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			CALHOUN KIRK K
		CENTRAL INDEX KEY:			0001203721

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51445
		FILM NUMBER:		051122857

	BUSINESS ADDRESS:	
		STREET 1:		11777 SAN VICENTE BLVD
		STREET 2:		STE 530
		CITY:			WEST LOS ANGELES
		STATE:			CA
		ZIP:			90024
		BUSINESS PHONE:		3104704222
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>y13123_kkc4.xml
<DESCRIPTION>MAIN DOCUMENT DESCRIPTION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2005-10-03</periodOfReport>

    <issuer>
        <issuerCik>0001319439</issuerCik>
        <issuerName>Adams Respiratory Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>ARXT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001203721</rptOwnerCik>
            <rptOwnerName>CALHOUN KIRK K</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>201 OCEAN AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>#B1004</rptOwnerStreet2>
            <rptOwnerCity>SANTA MONICA</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>09402</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2005-10-03</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>388</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>388</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>32.29</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2005-10-03</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>4000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2015-10-03</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The restricted stock units will vest in full on the first annual stockholders' meeting following the date of grant, or earlier in the case of certain terminations or change in control events.  Upon vesting the restricted stock units will automatically convert into deferred stock units, which will not be converted into our common stock until six months following a director's termination of board service.</footnote>
        <footnote id="F2">The options vest in five equal installments, beginning October 3, 2006.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Brad Cole, Attorney-in Fact</signatureName>
        <signatureDate>2005-10-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----